Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers

被引：16

作者：

Fujiwaki, R

Hata, T

Miyazaki, K

Kawamura, T

Inada, K

机构：

[1] Shimane Med Univ, Dept Obstet & Gynecol, Izumo, Shimane 693, Japan

[2] Chiyoda Cent Hosp, Dept Obstet & Gynaecol, Chiyoda, Japan

[3] Iwate Med Univ, Dept Anesthesiol, Morioka, Iwate 020, Japan

[4] Iwate Med Univ, Dept Bacteriol, Morioka, Iwate 020, Japan

来源：

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1997年 / 104卷 / 12期

关键词：

D O I：

10.1111/j.1471-0528.1997.tb11012.x

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

This study included 15 patients with gynaecological cancers (7 with cervical cancer, 6 with endometrial cancer, and 12 with ovarian cancer); 7 with benign gynaecological disorders (5 with benign ovarian tumour and 2 with uterine myoma); and 10 healthy women as a control group. Serum interleukin-l receptor antagonist (IL-1 ra) levels in patients with gynaecological cancer were significantly higher than those in patients with benign gynaecological disorders (P = 0.04) and in healthy controls (P = 0.0009). IL-1 ra may play an important role in host immune responses in local and general environments against gynaecological cancers.

引用

页码：1407 / 1408

页数：2

共 6 条

[1] BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].